Literature DB >> 5323968

Conference on obstacles to the control of acute leukemia. Studies on cross-resistance and collateral sensitivity (1962-1964).

D J Hutchison.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1965        PMID： 5323968

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  5 in total

1.  A curative combination cancer therapy achieves high fractional cell killing through low cross-resistance and drug additivity.

Authors:  Adam C Palmer; Christopher Chidley; Peter K Sorger
Journal:  Elife       Date:  2019-11-19       Impact factor: 8.140

2.  Collateral sensitivity of a methotrexate-resistant L1210 cell line to the vinca alkaloids.

Authors:  D G Poppitt; A T McGown; B W Fox
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

3.  Cyclophosphamide-resistant Yoshida ascites tumor cells and their cross resistance to some alkylating agents.

Authors:  H H Gerhartz; E Liss; H Schmidt
Journal:  J Cancer Res Clin Oncol       Date:  1979-07-27       Impact factor: 4.553

4.  Cross-drug resistance to sunitinib induced by doxorubicin in endothelial cells.

Authors:  Limin Huang; Chaoquan Hu; Mélanie DI Benedetto; Rémi Varin; Jielin Liu; Jian Jin; Li Wang; Jean-Pierre Vannier; Anne Janin; He Lu; Hong Li
Journal:  Oncol Lett       Date:  2014-12-22       Impact factor: 2.967

5.  Inherent and acquired resistance to paclitaxel in hepatocellular carcinoma: molecular events involved.

Authors:  Avtar Singh Meena; Aanchal Sharma; Ratna Kumari; Naoshad Mohammad; Shivendra Vikram Singh; Manoj Kumar Bhat
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.